Clorox Chief Operating Officer Completes Stock Transaction Amid Continued Executive Holdings

Executive Leadership Equity Activity at Clorox

Chris T. Hyder, who serves as Executive Vice President and Chief Operating Officer at The Clorox Company, completed an equity transaction involving common stock on July 15, 2026. The disclosure, filed on July 17, 2026, provides detailed insight into the nature and scope of this transaction as required under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting of beneficial ownership changes by company officers and directors.

Clorox is a multinational manufacturer and marketer of consumer products operating across multiple categories including cleaning, household, and personal care segments. The company's portfolio encompasses well-established brands such as Clorox bleach and cleaning products, Glad storage bags and trash containers, Burt's Bees natural personal care items, Kingsford charcoal, and Renew alternative cleaning products. The executive equity activity reflects typical stock management practices among senior leadership at major publicly traded consumer goods manufacturers.

Transaction Details and Share Withholding Mechanics

The reported transaction involved the acquisition of 277 shares of Clorox common stock at a price of $94.75 per share on the transaction date of July 15, 2026. This activity was classified under transaction code "F," which indicates that shares were withheld by the company as part of standard tax obligation satisfaction related to the vesting of restricted stock awards. This withholding mechanism is a common practice among publicly traded companies to cover applicable income tax liabilities arising from equity compensation arrangements.

The disclosure additionally noted that 36 of the shares included in the reported holdings were acquired pursuant to a dividend reinvestment feature available within the company's Stock Incentive Plan. This detail indicates that dividend payments on Hyder's existing stock holdings were automatically reinvested into additional common shares rather than being distributed as cash, a mechanism that allows shareholders to accumulate equity ownership over time through regular dividend income.

Beneficial Ownership Position Following Transaction

Following the completion of the transaction on July 15, 2026, Hyder's beneficial ownership of Clorox common stock totaled 76,860 shares held in direct form. This ownership represents shares registered directly in the executive's name rather than held indirectly through trusts, partnerships, or other ownership structures. The beneficial ownership figure reflects the aggregate position after accounting for all acquisitions, dispositions, and reinvestments completed through the transaction date.

Beneficial ownership calculations in corporate disclosures include not only shares held outright but also shares that an individual has the right to acquire within a specified timeframe, such as through the exercise of stock options or warrants. In this instance, the report indicates no derivative securities such as options or warrants were affected by the July 15, 2026 transaction, suggesting the activity was confined to direct common stock holdings and the mechanics of restricted stock vesting and tax withholding.

Restricted Stock Vesting and Equity Compensation Framework

The withholding of shares to satisfy tax obligations is a standard feature of restricted stock award programs used by major corporations to retain and incentivize executive leadership. When restricted stock vests, recipients face tax liabilities on the value of the shares at the vesting date, calculated based on the share price at that time. Rather than requiring executives to pay tax obligations in cash, many companies allow employees to satisfy this liability through the net settlement mechanism, whereby the company withholds a portion of newly vested shares to cover applicable taxes.

This approach provides operational convenience for both the company and the executive, eliminating the need for separate cash payments while ensuring that vesting events do not result in forced liquidation of positions. For Clorox, this practice reflects a compensation structure designed to align executive and shareholder interests through meaningful equity participation while managing the administrative complexity of tax withholding requirements associated with broad-based equity incentive programs.

Dividend Reinvestment Participation in Stock Incentive Plans

The inclusion of 36 shares acquired through dividend reinvestment indicates that Hyder participates in an optional or automatic dividend reinvestment program within Clorox's Stock Incentive Plan. Dividend reinvestment programs, commonly referred to as DRIPs, allow shareholders to redirect cash dividend payments into the purchase of additional shares rather than receiving the distribution as cash. This mechanism creates a compounding effect on equity positions over time, as reinvested dividends purchase additional shares that subsequently generate their own dividend income.

For executives holding substantial equity stakes in publicly traded companies, dividend reinvestment can be an effective wealth-building strategy during periods of stable or rising share valuations. Clorox's implementation of this feature within its formal Stock Incentive Plan suggests the company actively encourages long-term equity accumulation among key leadership personnel as part of its broader compensation and retention philosophy for executive management.

Transaction Code Classification and Reporting Requirements

The transaction was designated using code "F," which under Securities and Exchange Commission Form 4 instructions indicates a transaction involving the withholding of shares to satisfy tax withholding obligations. This classification ensures that investors and regulatory authorities can quickly identify the nature of the transaction without requiring detailed narrative explanation. The Form 4 reporting system utilizes standardized transaction codes to create consistency and clarity across the universe of insider trading disclosures filed by publicly traded companies.

By classifying the transaction with the specific code, Clorox's disclosure enables investors to distinguish between discretionary equity purchases made by the executive and automatic withholding events tied to equity compensation vesting. This distinction is important for investors analyzing executive compensation structures and incentive alignment, as voluntary purchases may signal greater confidence in the company's prospects compared to tax-related withholding mechanics that occur regardless of executive sentiment regarding future stock performance.

Filing Compliance and Corporate Governance Obligations

The disclosure was filed on July 17, 2026, two business days after the underlying transaction date, consistent with the prompt filing requirements applicable to Form 4 submissions. Chris T. Hyder's status as Executive Vice President and Chief Operating Officer triggers mandatory beneficial ownership reporting under Section 16 of the Securities Exchange Act, which requires designated corporate officers, directors, and significant shareholders to disclose changes in their holdings within specified timeframes. The timely filing of this disclosure demonstrates Clorox's compliance with applicable securities regulations governing insider equity transactions.

The report was executed by Jinho Joo, identified as attorney-in-fact, indicating delegation of signature authority for Form 4 filings to a designated company representative. This practice is standard among major corporations where compliance and legal departments manage the administrative mechanics of insider trading disclosures on behalf of reporting executives. The structured format and completeness of the disclosure reflects Clorox's internal controls and compliance procedures designed to ensure accurate and timely reporting of all material changes in executive beneficial ownership positions.

Market Context for Consumer Products Sector Executive Equity Management

Clorox operates within the consumer staples sector, which encompasses companies producing household, personal care, and food products distributed through retail channels globally. Within this sector, executive equity compensation and beneficial ownership tracking represent standard practices for aligning management incentives with shareholder returns. The company competes in markets including cleaning products, trash and food storage, natural personal care, charcoal, and other consumer categories where brand recognition and product innovation drive competitive positioning.

For investors analyzing Clorox from an executive compensation and governance perspective, regular monitoring of insider trading activity through Form 4 disclosures provides insight into management's confidence in the business and capital allocation decisions. While routine vesting and tax withholding transactions such as the one reported by Hyder do not necessarily signal directional views on future stock performance, they contribute to the public record of executive shareholding patterns and equity compensation execution that investors may consider alongside other governance metrics and financial performance indicators.

Disclosure Details and Direct Ownership Documentation

The disclosure specifies that all 76,860 shares in Hyder's beneficial ownership following the transaction are held in direct form, meaning they are registered in the executive's own name rather than through any intermediary structure. Direct ownership simplifies reporting mechanics and ensures clear documentation of executive equity stakes for regulatory, tax, and estate planning purposes. This structure contrasts with indirect beneficial ownership arrangements, which might involve holdings through family trusts, limited partnerships, or other entities that still require disclosure but involve different ownership structures.

Clorox's Form 4 disclosure provides the complete ownership picture required by securities regulations, enabling investors to understand both the scope of executive equity participation and the mechanics through which that participation is structured and maintained. The transaction price of $94.75 per share documented in the filing serves as a historical reference point for the vesting date valuation used in tax withholding calculations, information that supports transparency regarding the value of equity compensation awarded to senior leadership.